MYC and neoplasm: As current treatment options remain limited and often ineffective, focusing on MYC as a therapeutic target could pave the way for innovative treatments that specifically address the underlying molecular mechanisms driving tumor progression, ultimately enhancing the survival and quality of life for patients.